학술논문
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, noninferiority trial
Document Type
Article
Author
Pannus, P.; Depickère, S.; Houben, S.; Neven, K.Y.; De Craeye, S.; Francotte, A.; Chaumont, F.; Van Gucht, S.; Dierick, K.; Desombere, I.; Goossens, M.E.; Kemlin, D.; Olislagers, V.; Waegemans, A.; Marchant, A.; Heyndrickx, L.; Michiels, J.; Willems, E.; Ariën, K.K.; Verbrugghe, M.; Schmickler, M.-N.
Source
In: PLOS Global Public Health . (PLOS Global Public Health, December 2022, 2(12))
Subject
Language
English
ISSN
27673375